Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?
about
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm and/or low-birth-weight infantsEvidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitPredictors of bronchopulmonary dysplasiaPlatelet count and associated morbidities in VLBW infants with pharmacologically treated patent ductus arteriosus.Outcomes of primary ligation of patent ductus arteriosus compared with secondary ligation after pharmacologic failure in very-low-birth-weight infantsTranscriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone.Patent ductus arteriosus ligation and adverse outcomes: causality or bias?The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review.Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.Patent ductus arteriosus in premature neonates.The new bronchopulmonary dysplasia.Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?Effects of prophylactic indomethacin in extremely low-birth-weight infants with and without adequate exposure to antenatal corticosteroids.Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysisNeurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosusPotential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.Current Perspectives on Pathobiology of the Ductus Arteriosus.Clinical and echocardiographic characteristics associated with the evolution of the ductus arteriosus in the neonate with birth weight lower than 1,500g.Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus.Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.Patent ductus arteriosus in preterm infants: do we have the right answers?Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.The timing of surgical ligation for patent ductus arteriosus is associated with neonatal morbidity in extremely preterm infants born at 23-25 weeks of gestation.Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management.Patent ductus arteriosus in the preterm infant: to treat or not to treat?Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus.Learning to live with patency of the ductus arteriosus in preterm infants.Patent ductus arteriosus in preterm infants.Patent ductus arteriosus: wait and see?Oral ibuprofen for patent ductus arteriosus: effective and safe or just cheap? Commentary on R. Neumann et al.: Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants:Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.Judgment often impossible without randomized trials. Commentary on N. Patel: use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients (Neonatology 201Preterm patent ductus arteriosus: should we treat it?Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre.Epidemiology of bronchopulmonary dysplasia.Use of ultrasound in the haemodynamic assessment of the sick neonate.Management of patent ductus arteriosus in premature infants.Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosusEchocardiographic assessment of patent ductus arteriosus in very low birthweight infants over time: prospective observational study.
P2860
Q24201052-AF77BAA7-2BD0-4996-AD5E-EDD6CF901E78Q24604121-128C407D-FE0E-46F9-ABFB-EBCC0A6583F2Q26829843-C6152880-745E-4C45-9CEB-149E47B624ABQ33425812-B7B7B89D-64EA-402A-96E7-A2123AF19C4DQ33586223-EBAFAA1D-EC69-417F-9520-366816A9885AQ33840349-89DE8951-10D0-4660-AA01-9DC848634033Q33871314-91C84A6E-75B5-4F4B-A885-681973DA7A86Q34018364-C71889D7-369B-4EF7-A414-E435C07AC65FQ34517223-1223FF85-8F40-4AB9-9042-4FB50DB08BECQ35135932-9DAF5FA6-C37C-4499-AB31-97B1E579E21AQ35607990-C80C10E5-574F-43F1-98B6-1BB89F8FCA7BQ35693783-C71CA93D-1412-4295-9716-86C7855041C2Q35834962-E47E1894-964D-4D29-A654-4232C6AD2077Q36095667-821C5460-8D36-417B-87D2-E0B3155DA413Q36241148-08A60846-1F78-40B0-A655-2AE414B8AFA3Q36328450-AE35BDCD-99EC-4085-B078-21A9B6FFD981Q36484043-29364E98-CEED-415C-AF0B-F445A4DEBC0BQ36695955-1BD404E6-12E2-42C0-9B85-B3075FD255A2Q36931405-62239AF2-2C55-442A-9684-5750030BD0CEQ37302231-0770987C-5074-46A6-BC70-1629CF774BF6Q37324451-CB3481B1-FCAF-4942-99B9-D06B6B41A5EEQ37451050-A120F5E5-C304-4951-A91F-51563BF50E35Q37482391-7867E582-B2FD-4A70-A527-FBB8E32FEAE4Q37710387-23089017-46F4-4E2F-8F1B-FEB7771DB9D9Q37788264-AAC5FEBC-7E1E-420B-8F90-16901F6B6AF4Q37793846-54B56232-2D80-42D5-9565-DE87526F22C5Q37831102-5977E23E-D84B-4E4C-94AD-C6C4E941171EQ37859260-ED260DDF-A974-4708-86B9-74D64E9216FFQ37870606-50631C24-5902-487A-8AAB-CE5AB256C749Q37914874-99E9B082-5193-4241-8B25-DF40A83BC0DDQ37993358-00B6A2A7-11F7-49E0-BE78-94522EA242D0Q37998378-7F14FA64-7813-495A-B405-1161F8C9D109Q38019776-18C61544-D64D-4DC0-B451-5DBDB1A665B1Q38042655-78AAC1ED-38C0-4D12-8F34-A273472F1421Q38094688-D109963D-148A-4DAC-8230-1AD39DE96E7DQ38196792-E08C0C94-A4EA-4AC8-AC09-0E3753EE52DBQ38204877-0536FC88-D3EE-4FFD-83C8-B9D3D024DE53Q38297373-98C6C860-0E9A-4F7A-875F-22D81885E7B8Q38380099-1946DDC2-9F79-4C05-9EB3-7714B46BC32AQ38407110-589E0C9F-0F16-4DC7-BFEF-20C9951C7140
P2860
Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of persistent patent ...... to accept the null hypothesis?
@en
Treatment of persistent patent ...... to accept the null hypothesis?
@nl
type
label
Treatment of persistent patent ...... to accept the null hypothesis?
@en
Treatment of persistent patent ...... to accept the null hypothesis?
@nl
prefLabel
Treatment of persistent patent ...... to accept the null hypothesis?
@en
Treatment of persistent patent ...... to accept the null hypothesis?
@nl
P2860
P356
P1476
Treatment of persistent patent ...... to accept the null hypothesis?
@en
P2093
W E Benitz
P2860
P2888
P304
P356
10.1038/JP.2010.3
P577
2010-02-25T00:00:00Z
P6179
1053368169